May 24, 2013
May 22, 2013
They launched the 'Arab Spring' but now yearn for the good old days of a strongman
May 20, 2013
Richard A. Serrano: Is Meir Kahane's assassin now a changed man?
Genetic copies of living people from embryos no longer science fiction
Jewz in the Newz by Nate Bloom :
The Kosher Gourmet by Cathy Pollak:
Jews Inducted into Rock Hall of Fame; Anton Yelchin co-stars in New "Trek" film; Kutcher (but not Kunis) visits Israel; Jewish TV Star Praises Jewish Rap Star
WARNING: This WALNUT CAKE WITH PRALINE FROSTING, perfect for afternoon coffee, is addicting
May 13, 2013
Rabbi Nathan Lopes Cardozo: Why the giving of the document that would permanently change the world could only be done in desolation
David G. Savage:
Church-state, literally? Supreme Court weighing public school graduation in a church
May 10, 2013
Rabbi Berel Wein: Be all that you should be
May 8, 2013
Peter Ford: Why China is welcoming both Israel's Netanyahu and Palestinians' Abbas
Obama administration quietly backs out of appeal over new contraceptive mandate
At Kerry-Putin meeting, US-Russia relations thaw --- a tad
The Kosher Gourmet by Leela Cyd Ross :
Almost too pretty to eat, this colorful salad with Sicilian inspiration will tickle the taste buds and delight your visual sensibility
May 6, 2013
May 3, 2013
Kids, kittens the Same?
With employee perks at struggling Internet pioneer Yahoo! it's hard to tell
Artificial kidney offers hope to patients tethered to a dialysis machine
April 29, 2013
Poland's new Jewish museum celebrates life, doesn't revisit Holocaust
Terrorism in America: Is US missing a chance to learn from failed plots?
Boston Bomber's 'Svengali' Revealed
Tiny satellites + cellphones = cheaper 'eyes in the sky' for NASA
April 26, 2013
Clifford D. May:
Defense in the Age of Jihadist Terrorism
Sharon Palmer, R.D.:
How to feel your best -- with plenty of energy, a healthy weight and optimal mental and physical function -- without driving yourself batty
April 24, 2013
Jewish World Review
Ask the Harvard Experts: Hepatitis C not responsive to herbal therapy
Howard LeWine, M.D.
Q: I just found out that I have hepatitis C. I feel fine. I heard that milk thistle is good for the liver. Does it help people with hepatitis C?
A: More than 3 million Americans are infected with the virus that causes hepatitis C. About three-quarters of them are baby boomers -- anyone born between 1945 and 1965. Many of them got it through a blood transfusion.
Like you, most people are not aware they've been infected with the virus unless they get tested. Even without symptoms, chronic hepatitis C can cause the liver to become inflamed as the body fights the infection. Inflamed liver tissue can become scarred. Scar tissue replaces healthy tissue.
|FREE SUBSCRIPTION TO INFLUENTIAL NEWSLETTER|
Every weekday JewishWorldReview.com publishes what many in the media and Washington consider "must-reading". In addition to INSPIRING stories, HUNDREDS of columnists and cartoonists regularly appear. Sign up for the daily update. It's free. Just click here.
The liver is a resilient organ. It can heal if the illness is caught and treated successfully. But when scarring continues and becomes serious, it leads to cirrhosis and a poorly functioning liver.
More than half of Americans seek alternative treatments for medical ailments. There is the perception that milk thistle helps heal a damaged liver, so it's not surprising that many people with hepatitis C use it, alone or combined with doctor-prescribed drugs.
According to the results of a study just published in the Journal of the American Medical Association, silymarin was no more effective than a placebo. Silymarin is the active ingredient in milk thistle extract.
Two different doses of silymarin were tested. One of the doses was much higher than what most people take. But even that dose did not appear to dampen liver inflammation. Although the study didn't specifically address side effects, milk thistle extract did not appear to cause harm.
It's great that you got tested for the virus. The U.S. Centers for Disease Control and Prevention recommends that anyone born between 1945 and 1965 should have a one-time blood test for hepatitis C. Younger people at increased risk should also get tested.
Treatments can slow the infection and limit the damage hepatitis C causes. The first treatment used is pegylated interferon plus ribavirin. It's the most effective. But response rates are only 50 percent to 60 percent.
The U.S. Food and Drug Administration has approved two new antiviral drugs to treat hepatitis C. They are boceprevir (Victrelis) and telaprevir (Incivek). Either one can be combined with interferon and ribavirin. This triple therapy is 30 percent more effective than the standard double therapy.
(Howard LeWine, M.D., is a practicing internist at Brigham and Women's Hospital, Boston, Mass., and Chief Medical Editor of Internet Publishing at Harvard Health Publications, Harvard Medical School.)
Interested in a private Judaic studies instructor for free? Let us know by clicking here.
Sign up for the daily JWR update. It's free. Just click here.
To comment, please click here.
© 2012, PRESIDENT AND FELLOWS OF HARVARD COLLEGE. ALL RIGHTS RESERVED. DISTRIBUTED BY TRIBUNE MEDIA SERVICES, INC.